Skip to main content

Month: February 2021

Red Light Holland Announces Increase in Bought Deal Equity Financing to $10 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Red Light Holland Corp. (“Red Light Holland” or the “Company”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has entered into an amended agreement with Eight Capital, pursuant to which Eight Capital has now agreed to buy, on a bought deal basis, 23,000,000 units (“Units”) at a price of $0.44 per Unit (the “Issue Price”), for gross proceeds of $10,120,000 (the “Offering”).The Company has agreed to grant Eight Capital an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable...

Continue reading

Telos Awarded $13.5M FBI Contract for Enterprise Risk Management

ASHBURN, Va., Feb. 03, 2021 (GLOBE NEWSWIRE) — Telos® Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it was awarded a contract valued at approximately $13.5 million, including options, by the Federal Bureau of Investigation (FBI) to deploy its Xacta solution and establish an interactive, real-time risk assessment capability across its risk management framework workloads.The base contract is valued at over $4M and runs for a one year period, with four option years. As part of the contract, Telos will provide governance, risk management and compliance (GRC) support to the FBI’s Enterprise Information Security Section while optimizing technology, people and processes. Additionally, Telos will install, integrate...

Continue reading

Essential Oils Market to Rise at 9.65% CAGR till 2026; Increasing Applications in Cosmetics Industry to Provide Impetus to Growth, says Fortune Business Insights

Pune, India, Feb. 03, 2021 (GLOBE NEWSWIRE) — According to a recent report published by Fortune Business Insights™, the global essential oils market size is projected to reach USD 14.6 billion by the end of 2026.  The market was worth 7.03 billion in 2018 and will exhibit a CAGR of 9.65% in the forecast period 2019-2026.Essential oils are hydrophobic liquids that are extracted from plants. The oils capture scent and flavor or essence from the sources that they are derived. The growing trend of ‘green’ consumerism has primarily driven the adoption of essential oils. Additionally, the demand for naturally-derived products and their increasing preference over its synthetic counterparts will provide opportunities for market growth. The advances in ingredient formulation have enabled variations in product offerings. As a result, there...

Continue reading

Golar LNG Partners LP Announces Filing of Its Proxy Statement Ahead of Special Meeting for Proposed Merger With New Fortress Energy

Golar LNG Partners LP (NASDAQ: GMLP) (“GMLP”) announces that it filed its proxy statement with the SEC on February 2, 2021, ahead of the special meeting of its unitholders scheduled to take place on February 24, 2021. At the special meeting, the holders of GMLP’s common units will vote on the previously announced proposed merger of GMLP and an indirect subsidiary of New Fortress Energy Inc. (“NFE”), as contemplated by GMLP’s Third Amended and Restated Agreement of Limited Partnership dated October 31, 2017.  As previously announced, GMLP common unitholders of record at the close of business on January 25, 2021 will receive notice of the special meeting and be entitled to vote at the special meeting.FORWARD LOOKING STATEMENTSThis press release contains certain forward-looking statements concerning future events. Forward-looking statements...

Continue reading

Information Received

Panevezio statybos trestas AB received a notice from the European Court of Human Rights (ECHR) through the authorised person confirming that the application by PST had been registered for preliminary proceedings.PST exercised the right of the legal person to turn to the European Court of Human Rights for protection of business interests in application of the Convention for the Protection of Human Rights and Fundamental Freedoms. PST went to the ECHR for possible infringement of Article 6 of the Convention and Paragraph 1 Article 1 Protocol 1 to the Convention, which had been possibly infringed by the Lithuanian Administrative Courts in hearing the appeals by PST on vacation of the judgement No. 2S-11(2017) dated 20 December 2017 by the Competition Council.More information:Managing DirectorEgidijus UrbonasTel.: (+370 45) 505 503

Continue reading

Dėl gautos informacijos

AB „PANEVĖŽIO STATYBOS TRESTAS“ per įgaliotą atstovą gavo Europos Žmogaus Teisių Teismo (EŽTT) pranešimą, kuriame patvirtinta, kad PST pareiškimas užregistruotas preliminariam nagrinėjimui.PST pasinaudojo juridinio asmens teise kreiptis į EŽTT dėl verslo interesų gynimo taikant Žmogaus teisių ir pagrindinių laisvių apsaugos konvenciją. PST kreipėsi į EŽTT dėl Konvencijos 6 straipsnio ir šios Konvencijos Pirmojo protokolo 1 straipsnio 1 dalies galimų pažeidimų, kuriuos Lietuvos administraciniai teismai galimai pažeidė nagrinėdami PST skundus dėl Konkurencijos tarybos 2017 m. gruodžio 20 d. nutarimo Nr.2S-11(2017) panaikinimo.Daugiau informacijos:Generalinis direktoriusEgidijus UrbonasTel.: (8-45) 505 503

Continue reading

Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM

The access information for the investor conference call is as follows:Domestic US/Canada – 1-(866) 342-8588Direct Toll / International – 1-(203) 518-9865Program Title: Generex Biotechnology Conference CallConference ID – 61174AgendaUpdate on Ii-Key-SARS-CoV-2 vaccine programChina Licensing & Research Agreement advances with $100,000payment guarantee and $1 million advance on development fundingLicensing opportunity for COVID-19 therapeutic antibodiesMIRAMAR, Fla., Feb. 03, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced the call-in information and an updated agenda for the shareholder conference call on Friday February 5th at 9:00 am.During the call, Generex President & CEO Joe Moscato will discuss the agenda as well as new developments with the COVID-19...

Continue reading

REPEAT – Pure Extracts Announces Submission for Class 1 Natural Product Number (NPN)

VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, focused on cannabis, hemp, functional mushrooms, and the rapidly emerging psychedelic sector, is pleased to announce that it recently completed its new company registration with the Natural and Non-prescription Health Products Directorate (NNHPD) and received its Company Code. This has allowed Pure Extracts to submit a Class 1 Natural Product Number (NPN) application for a functional mushroom product, which the Company expects will be the first of several NPN applications that it submits in 2021.Pure Extracts plans to sell functional mushroom wellness products through its newly incorporated, wholly owned subsidiary, Pure Mushrooms...

Continue reading

Natural Health Trends to Report Fourth Quarter and Full Year 2020 Financial Results on February 10th

HONG KONG, Feb. 03, 2021 (GLOBE NEWSWIRE) — Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and “quality of life” products under the NHT Global brand, today announced the Company will report its financial results for the fourth quarter and full year ended December 31, 2020 on Wednesday, February 10, 2021 at 9:00 a.m. Eastern Time. Chris Sharng, Natural Health Trends’ President, and Scott Davidson, Senior Vice President and Chief Financial Officer, will host a conference call to discuss the fourth quarter and full year 2020 financial results on the same day at 11:30 a.m. Eastern Time. The details for the conference call can be found below.Fourth Quarter and Full Year 2020 Financial Results Conference CallAbout Natural Health Trends Corp.Natural...

Continue reading

Column Leach Test Results Exceed Expectations for the Cheechoo Gold Project, Quebec

MONTREAL, Feb. 03, 2021 (GLOBE NEWSWIRE) — The management of Sirios Resources Inc. (TSXV: SOI) is pleased to announce the results of metallurgical tests that were performed on approximately 500 kg of a composite sample material, representative of gold mineralization on the Cheechoo property. These tests, performed by the renowned firm KCA over several months in Reno, Nevada, were completed in January 2021.After 151 days of column leaching, with a crushing size of 6.3 mm, gold recoveries were 80% at 20°C and 76% at 4°C (Table 1). The tests were conducted at various temperatures to simulate conditions that could be encountered in an environment simulating crushed and stacked mineralized material in the Cheechoo Project area. The average gold recovery results obtained were 78%, which is higher than the typical gold recoveries for heap...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.